Dallas, Texas, United States The company was established in North America in United States. The main office of represented VC is situated in the Dallas.
The important activity for fund was in 2004. The increased amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 4 participants. The meaningful sponsors for the fund in investment in the same round are The University of Texas at Austin, Startech Early Ventures, Cardinal Investment Co.. In the next rounds fund is usually obtained by Novo Holdings, CPMG.
Among the most successful fund investment fields, there are Biopharma, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Reata Pharmaceuticals.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Babilou | Courbevoie, France, Ile-de-France |
| Cap-Meridian Ventures | New York, New York, United States |
| Chasestone Capital | China, Shanghai |
| Chesapeake Energy | Oklahoma, Oklahoma City, United States |
| Chiba Dojo | Japan, Tokyo |
| Devenish Nutrition | Fairmont, Minnesota, United States |
| Dollar General | Goodlettsville, Tennessee, United States |
| Elliott Management Corp. | New York, New York, United States |
| Equinix Japan | Japan, Tokyo |
| First Stone Venture Partners | - |
| Himachal Futuristic Communications Limited | - |
| IIX Asia | Central, Central Region, Singapore |
| Jinyuan Development Company | - |
| Macro | California, Los Angeles, United States |
| Qingdao Chuban Touzi Youxian Gongsi | China, Qingdao Shi, Shandong |
| Rio Tinto | Australia, Melbourne, Victoria |
| Sibling Capital | California, Rancho Santa Fe, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Reata Pharmaceuticals | $12M | 12 Nov 2004 | Irving, Texas, United States | ||
Reata Pharmaceuticals | $3M | 12 Sep 2003 | Irving, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Reata Pharmaceuticals | $12M | 12 Nov 2004 | Irving, Texas, United States | ||
Reata Pharmaceuticals | $3M | 12 Sep 2003 | Irving, Texas, United States |
